Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST

SHE:002755 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,2841,4221,4111,047772.711,166
Trading Asset Securities
1,1971,059683.28713.83839.08522.39
Cash & Short-Term Investments
2,4812,4812,0951,7611,6121,688
Cash Growth
8.71%18.43%18.96%9.25%-4.51%14.90%
Accounts Receivable
201.65279.17231.83181.24323.03581.86
Other Receivables
6.666.7713.0249.8825.2116.29
Receivables
208.31285.94244.85231.12348.23598.15
Inventory
117.69124.55196.99167.49141.53141.84
Other Current Assets
114.6899.2431.592736.5659.14
Total Current Assets
2,9212,9912,5682,1862,1382,487
Property, Plant & Equipment
407.46415.06474.03478.4547.14658.33
Long-Term Investments
47.147.61118.72118.21107.57105.18
Other Intangible Assets
562.28578.89146.3498.3495.7797.69
Long-Term Deferred Tax Assets
24.6524.6524.6225.7325.8528.69
Long-Term Deferred Charges
524.5423.1676.78563.46453.7342.02
Other Long-Term Assets
36.0137.2638.9753.2646.225.75
Total Assets
4,5234,5174,0483,5243,4143,725
Accounts Payable
47.32121.0759.9838.2939.0865.72
Accrued Expenses
7.5626.7540.8443.6119.56133.48
Short-Term Debt
-2762114.0245.03-
Current Portion of Long-Term Debt
2.882.79----
Current Portion of Leases
--4.063.033.452.61
Current Income Taxes Payable
36.842.062.053.592.137.54
Current Unearned Revenue
237.97282108.5115.8811.6815.26
Other Current Liabilities
736.63665.16543.53213.14102.81177.11
Total Current Liabilities
1,0691,167820.96431.55323.74401.71
Long-Term Leases
3.434.046.626.758.9211.52
Long-Term Unearned Revenue
54.9956.160.6664.7255.8168.93
Long-Term Deferred Tax Liabilities
16.0116.0117.1510.1812.5615.08
Total Liabilities
1,1441,243905.39513.2401.03497.24
Common Stock
928.16928.16928.16928.16928.16928.16
Additional Paid-In Capital
163.64163.64136.94136.9450.730.94
Retained Earnings
2,1982,1141,9891,8281,9772,295
Comprehensive Income & Other
10.829.788.956.587.25-5.9
Total Common Equity
3,3013,2153,0632,9002,9633,219
Minority Interest
78.7358.7179.59110.750.378.82
Shareholders' Equity
3,3803,2743,1423,0113,0133,228
Total Liabilities & Equity
4,5234,5174,0483,5243,4143,725
Total Debt
6.3133.8372.67123.857.4114.13
Net Cash (Debt)
2,4742,4472,0221,6371,5541,674
Net Cash Growth
11.10%21.01%23.52%5.32%-7.14%15.51%
Net Cash Per Share
2.602.592.141.761.651.81
Filing Date Shares Outstanding
938.54994.19928.16928.16928.16928.16
Total Common Shares Outstanding
938.54994.19928.16928.16928.16928.16
Working Capital
1,8521,8241,7471,7551,8142,085
Book Value Per Share
3.523.233.303.123.193.47
Tangible Book Value
2,7392,6372,9162,8022,8673,121
Tangible Book Value Per Share
2.922.653.143.023.093.36
Buildings
--385.96375.5371.29437.94
Machinery
--804.36744.21767.2776.51
Construction In Progress
--23.5136.0729.819.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.